MX2007003118A - Procedimiento de intermediarios para preparar inhibidores de cisteina proteasa. - Google Patents
Procedimiento de intermediarios para preparar inhibidores de cisteina proteasa.Info
- Publication number
- MX2007003118A MX2007003118A MX2007003118A MX2007003118A MX2007003118A MX 2007003118 A MX2007003118 A MX 2007003118A MX 2007003118 A MX2007003118 A MX 2007003118A MX 2007003118 A MX2007003118 A MX 2007003118A MX 2007003118 A MX2007003118 A MX 2007003118A
- Authority
- MX
- Mexico
- Prior art keywords
- protease inhibitors
- intermediates
- processes
- cysteine protease
- preparing cysteine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C07C315/02—Preparation of sulfones; Preparation of sulfoxides by formation of sulfone or sulfoxide groups by oxidation of sulfides, or by formation of sulfone groups by oxidation of sulfoxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
- C07C321/12—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms
- C07C321/16—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
- C07D213/34—Sulfur atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invencion se dirige a un nuevo procedimiento para preparar inhibidores de proteasa cisteina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61080604P | 2004-09-17 | 2004-09-17 | |
PCT/US2005/033051 WO2006034004A2 (en) | 2004-09-17 | 2005-09-16 | Processes and intermediates for preparing cysteine protease inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007003118A true MX2007003118A (es) | 2007-05-24 |
Family
ID=35899659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007003118A MX2007003118A (es) | 2004-09-17 | 2005-09-16 | Procedimiento de intermediarios para preparar inhibidores de cisteina proteasa. |
Country Status (15)
Country | Link |
---|---|
US (1) | US7737300B2 (es) |
EP (1) | EP1799645A2 (es) |
JP (1) | JP2008513472A (es) |
KR (1) | KR20070061877A (es) |
CN (1) | CN101068783A (es) |
AU (1) | AU2005287046A1 (es) |
BR (1) | BRPI0515470A (es) |
CA (1) | CA2580065A1 (es) |
CR (1) | CR8993A (es) |
EC (1) | ECSP077321A (es) |
IL (1) | IL181792A0 (es) |
MX (1) | MX2007003118A (es) |
NO (1) | NO20071937L (es) |
WO (1) | WO2006034004A2 (es) |
ZA (1) | ZA200703102B (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060079143A (ko) | 2003-09-18 | 2006-07-05 | 액시스 파마슈티컬스 인코포레이티드 | 시스테인 프로테아제 억제제로서의 할로알킬 함유 화합물 |
EP1819667B1 (en) | 2004-12-02 | 2012-10-17 | ViroBay, Inc. | Sulfonamide compounds as cysteine protease inhibitors |
KR101447897B1 (ko) | 2005-03-21 | 2014-10-07 | 비로베이, 인코포레이티드 | 시스테인 단백질분해효소 억제제로서의 알파 케토아미드화합물 |
MX2007011739A (es) | 2005-03-22 | 2008-03-14 | Celera Genomics | Compuestos que contienen sulfonilo como inhibidores de cisteina proteasa. |
US20090270511A1 (en) * | 2006-09-08 | 2009-10-29 | Merck Frosst Canada Ltd. | Prodrugs of inhibitors of cathepsin s |
EP2076490A4 (en) * | 2006-09-25 | 2010-07-28 | Merck Frosst Canada Ltd | INHIBITORS OF CATHEPSIN B |
ZA200902477B (en) | 2006-10-04 | 2010-08-25 | Virobay Inc | Di-fluoro containing compounds as cysteine protease inhibitors |
US7893112B2 (en) | 2006-10-04 | 2011-02-22 | Virobay, Inc. | Di-fluoro containing compounds as cysteine protease inhibitors |
US8450336B2 (en) | 2006-12-14 | 2013-05-28 | Nps Pharmaceuticals, Inc | Use of D-serine derivatives for the treatment of anxiety disorders |
US8273913B2 (en) | 2007-04-02 | 2012-09-25 | Merck Canada Inc. | Amidation process for the preparation of cathepsin K inhibitors |
AU2009303468B2 (en) | 2008-10-17 | 2014-08-28 | Xenon Pharmaceuticals Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
EP2445872A4 (en) * | 2009-06-22 | 2012-12-05 | Merck Canada Inc | INHIBITORS OF CATHEPSINE CYSTEINE PROTEASE FOR TREATING VARIED DISEASES |
US8324417B2 (en) | 2009-08-19 | 2012-12-04 | Virobay, Inc. | Process for the preparation of (S)-2-amino-5-cyclopropyl-4,4-difluoropentanoic acid and alkyl esters and acid salts thereof |
WO2012119941A1 (en) | 2011-03-04 | 2012-09-13 | Prozymex A/S | Peptidyl nitrilcompounds as peptidase inhibitors |
EP2720692A4 (en) * | 2011-06-17 | 2015-05-20 | Virobay Inc | CATHEPSIN INHIBITORS FOR TREATING NEURONAL LOSS IN MICROGLIE MEDIATION IN THE CENTRAL NERVOUS SYSTEM |
EP3342765B1 (en) * | 2015-08-29 | 2021-09-15 | Sunshine Lake Pharma Co., Ltd. | Cathepsin k inhibitor and application thereof |
CN106478564B (zh) * | 2015-08-29 | 2021-11-12 | 广东东阳光药业有限公司 | 组织蛋白酶k抑制剂及其用途 |
EP3946332A1 (en) | 2019-04-05 | 2022-02-09 | Université de Bretagne Occidentale | Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxic poisoning |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9723407D0 (en) * | 1997-11-05 | 1998-01-07 | Ciba Geigy Ag | Organic compounds |
ATE479651T1 (de) * | 1997-11-05 | 2010-09-15 | Novartis Pharma Gmbh | Dipeptide nitrile |
AU2560300A (en) * | 1999-02-20 | 2000-09-04 | Astrazeneca Ab | Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsins |
WO2003029200A2 (en) * | 2001-10-02 | 2003-04-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compounds useful as reversible inhibitors of cysteine proteases |
AU2003219953B8 (en) * | 2002-03-05 | 2008-09-25 | Axys Pharmaceuticals, Inc. | Cathepsin cysteine protease inhibitors |
JP4076955B2 (ja) * | 2002-03-11 | 2008-04-16 | 花王株式会社 | 化粧料 |
-
2005
- 2005-09-16 AU AU2005287046A patent/AU2005287046A1/en not_active Abandoned
- 2005-09-16 MX MX2007003118A patent/MX2007003118A/es not_active Application Discontinuation
- 2005-09-16 US US11/662,933 patent/US7737300B2/en active Active
- 2005-09-16 BR BRPI0515470-7A patent/BRPI0515470A/pt not_active Application Discontinuation
- 2005-09-16 WO PCT/US2005/033051 patent/WO2006034004A2/en active Application Filing
- 2005-09-16 CN CNA2005800389964A patent/CN101068783A/zh active Pending
- 2005-09-16 KR KR1020077008584A patent/KR20070061877A/ko not_active Application Discontinuation
- 2005-09-16 JP JP2007532479A patent/JP2008513472A/ja active Pending
- 2005-09-16 CA CA002580065A patent/CA2580065A1/en not_active Abandoned
- 2005-09-16 EP EP05796693A patent/EP1799645A2/en not_active Withdrawn
-
2007
- 2007-03-08 IL IL181792A patent/IL181792A0/en unknown
- 2007-03-15 EC EC2007007321A patent/ECSP077321A/es unknown
- 2007-03-15 CR CR8993A patent/CR8993A/es unknown
- 2007-04-16 NO NO20071937A patent/NO20071937L/no not_active Application Discontinuation
- 2007-04-16 ZA ZA200703102A patent/ZA200703102B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO2006034004A3 (en) | 2006-11-23 |
KR20070061877A (ko) | 2007-06-14 |
IL181792A0 (en) | 2007-07-04 |
CR8993A (es) | 2007-10-04 |
WO2006034004A2 (en) | 2006-03-30 |
JP2008513472A (ja) | 2008-05-01 |
CA2580065A1 (en) | 2006-03-30 |
ZA200703102B (en) | 2009-09-30 |
CN101068783A (zh) | 2007-11-07 |
US20080114175A1 (en) | 2008-05-15 |
NO20071937L (no) | 2007-06-15 |
EP1799645A2 (en) | 2007-06-27 |
US7737300B2 (en) | 2010-06-15 |
AU2005287046A1 (en) | 2006-03-30 |
BRPI0515470A (pt) | 2008-07-22 |
ECSP077321A (es) | 2007-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007003118A (es) | Procedimiento de intermediarios para preparar inhibidores de cisteina proteasa. | |
TW200639161A (en) | Process for the purification of duloxetine hydrochloride | |
TW200732836A (en) | Method for expelling gas positioned between a substrate and a mold | |
GB2432609A (en) | Method of expansion | |
HK1096956A1 (en) | Cysteine protease inhibitors | |
MY147732A (en) | Process for the preparation of 2-substituted-5- (1-alkylthio) alkylpyridines | |
TW200716525A (en) | Process for preparation of sulfamide derivatives | |
TW200728310A (en) | Process for the preparation of ferri-succinylcasein | |
TWI365876B (en) | Prodrugs of hiv protease inhibitors | |
UA97241C2 (uk) | Спосіб одержання інгібіторів віл-протеази | |
MX2011011272A (es) | Procesos e intermediarios. | |
IL177055A0 (en) | Silinae compounds as cysteine protease inhibitors | |
IN2012DN01968A (es) | ||
GB0513841D0 (en) | Cysteine protease inhibitors | |
MX2012003488A (es) | Proceso para la elaboracion de n-acil-bifenil-alanina. | |
IL189286A0 (en) | Novel cysteine protease inhibitors and their therapeutic applications | |
SG158860A1 (en) | Processes for the preparation of aminoethoxybenzyl alcohols | |
EP1706402A4 (en) | INHIBITORS OF CATHEPSINE TYPE PROTEIN CYSTEINES | |
GB0513840D0 (en) | Cysteine protease inhibitors | |
GB0513839D0 (en) | Cysteine protease inhibitors | |
TW200728267A (en) | Processes and intermediates for the preparation of prostaglandins | |
EP1715920A4 (en) | CATHEPSINCYSTEINPROTEASEHEMMER | |
IL184519A0 (en) | Protease inhibitor precursor synthesis | |
UA94391C2 (ru) | Синтез предшественника ингибитора протеазы | |
TW200745060A (en) | Novel process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC | Change of company name or juridical status |
Owner name: JAMES HARDIE INTERNATIONAL FINANCE B.V. |
|
FA | Abandonment or withdrawal |